Lack of optimal activation of natural killer levels by interleukin-2 in rat spleen cells: Evidence for suppression
- 31 August 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 122 (2), 548-554
- https://doi.org/10.1016/0008-8749(89)90100-7
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.The Journal of Experimental Medicine, 1986
- Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated LymphocytesAnnual Review of Immunology, 1986
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Isolation of human and rat natural killer cellsJournal of Immunological Methods, 1982
- Defective T-cell response in beige mutant miceNature, 1982
- Modulation of Natural Cytotoxicity by AlloantibodiesThe Journal of Immunology, 1979